We are live on
!
Find out more
Viking Therapeutics
VKTX
VKTX
138 hedge funds and large institutions have $290M invested in Viking Therapeutics in 2020 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 43 increasing their positions, 45 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
282% more call options, than puts
Call options by funds: $13.4M | Put options by funds: $3.5M
57% more capital invested
Capital invested by funds: $185M → $290M (+$105M)
11% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 18
0.96% more ownership
Funds ownership: 54.46% → 55.42% (+0.96%)
1% more funds holding
Funds holding: 137 → 138 (+1)
4% less repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 45
Holders
138
Holders Change
+1
Holders Change %
+0.73%
% of All Funds
2.83%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
43
Reduced
45
Closed
18
Calls
$13.4M
Puts
$3.5M
Net Calls
+$9.86M
Net Calls Change
+$5.04M
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
+$4.22M |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$4.15M |
| 3 |
Goldman Sachs
New York
|
+$3.27M |
| 4 |
Two Sigma Investments
New York
|
+$3.07M |
| 5 |
Millennium Management
New York
|
+$2.35M |
Top Sellers
| 1 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$2.56M |
| 2 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$2.4M |
| 3 |
Aviva
London,
United Kingdom
|
-$1.86M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.84M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$1.65M |
